Furthermore, in a mouse model of prostate cancer, haploinsufficiency of the Pten gene leads to increased rates of tumor progression, without evidence of mutations in the retained Pten allele; this is similar to the situation in many human prostate cancers [18]. This evidence concerns the gene PTEN and prostate carcinoma.